BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18549361)

  • 41. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioids in headache.
    Levin M
    Headache; 2014 Jan; 54(1):12-21. PubMed ID: 24127913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of strong opioids in the treatment of the chronic musculoskeletal pain].
    Cwiek R; Gasik R; Lisowska B
    Pol Merkur Lekarski; 2008 Jun; 24(144):552-5. PubMed ID: 18702342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Non-opioid and opioid medication in neuropathic pain].
    Uyar M; Eyigör C
    Agri; 2008 Oct; 20(4):6-16. PubMed ID: 19117151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid syndrome: failed opioid therapy for chronic noncancer pain.
    Kamen LB; Feeko KJ
    Phys Med Rehabil Clin N Am; 2014 May; 25(2):375-95. PubMed ID: 24787339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An opioid screening instrument: long-term evaluation of the utility of the Pain Medication Questionnaire.
    Holmes CP; Gatchel RJ; Adams LL; Stowell AW; Hatten A; Noe C; Lou L
    Pain Pract; 2006 Jun; 6(2):74-88. PubMed ID: 17309714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cognitive effects of opioids].
    Grisart J
    Rev Med Suisse; 2009 Jun; 5(208):1356-8, 1360-3. PubMed ID: 19626760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.
    Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB
    Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urine toxicology testing in chronic pain management.
    Cone EJ; Caplan YH
    Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid side effects and their treatment in patients with chronic cancer and noncancer pain.
    McNicol E
    J Pain Palliat Care Pharmacother; 2008; 22(4):270-81. PubMed ID: 21923311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Opioids in the treatment of pain--efficient weapon in the expert's hand].
    Kalso E
    Duodecim; 2004; 120(2):195-6. PubMed ID: 15065513
    [No Abstract]   [Full Text] [Related]  

  • 54. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
    Porreca F; Ossipov MH
    Pain Med; 2009; 10(4):654-62. PubMed ID: 19302436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic pain and opioids: dispelling myths and exploring the facts.
    Mann E
    Prof Nurse; 2003 Mar; 18(7):408-11. PubMed ID: 12674051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normal-release oral morphine starting dose in cancer patients with pain.
    Ripamonti CI; Campa T; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; De Conno F;
    Clin J Pain; 2009 Jun; 25(5):386-90. PubMed ID: 19454871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opioids in chronic non-cancer pain.
    Chan BK; Tam LK; Wat CY; Chung YF; Tsui SL; Cheung CW
    Expert Opin Pharmacother; 2011 Apr; 12(5):705-20. PubMed ID: 21254859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nerve growth factor and chronic daily headache: a potential implication for therapy.
    Sarchielli P; Gallai V
    Expert Rev Neurother; 2004 Jan; 4(1):115-27. PubMed ID: 15853622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
    Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
    Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic opioid treatment of intractable, non-malignant pain.
    Tennant F; Robinson D; Sagherian A; Seecof R
    NIDA Res Monogr; 1988; 81():174-80. PubMed ID: 3136358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.